Motakef Saba, Mountziaris Paschalia M, Ismail Inzhili K, Agag Richard L, Patel Ashit
Loma Linda, Calif.; and Albany, N.Y. From the Department of Plastic Surgery, Loma Linda University Medical Center; and the Department of Surgery, Division of Plastic Surgery, Albany Medical Center.
Plast Reconstr Surg. 2015 Jan;135(1):290-299. doi: 10.1097/PRS.0000000000000839.
Microsurgical free tissue transfer has become an increasingly valuable technique in reconstructive surgery. However, there is a paucity of evidence-based guidelines to direct management. A systematic review was performed to define strategies to optimize perioperative management.
A systematic review of the literature was performed using key search terms. Strategies to guide patient management were identified, classified according to level of evidence, and used to devise recommendations in seven categories: patient temperature, anesthesia, fluid administration/blood transfusion, vasodilators, vasopressors, and anticoagulation.
A total of 106 articles were selected and reviewed. High-level evidence was identified to guide practices in several key areas, including patient temperature, fluid management, vasopressor use, anticoagulation, and analgesic use.
Current practices remain exceedingly diverse. Key strategies to improve patient outcomes can be defined from the available literature. Key evidence-based guidelines included that normothermia should be maintained perioperatively to improve outcomes (level of evidence 2b), and volume replacement should be maintained between 3.5 and 6.0 ml/kg per hour (level of evidence 2b). Vasopressors do not harm outcomes and may improve flap flow (level of evidence 1b), with most evidence supporting the use of norepinephrine over other vasopressors (level of evidence 1b). Dextran should be avoided (level of evidence 1b), and pump systems for local anesthetic infusion are beneficial following free flap breast reconstruction (level of evidence 1b). Further prospective studies will improve the quality of available evidence.
显微外科游离组织移植已成为重建外科中一项越来越有价值的技术。然而,指导管理的循证指南却很匮乏。进行了一项系统评价以确定优化围手术期管理的策略。
使用关键检索词对文献进行系统评价。确定指导患者管理的策略,根据证据水平进行分类,并用于制定七个类别的建议:患者体温、麻醉、液体输注/输血、血管扩张剂、血管升压药和抗凝。
共筛选并审查了106篇文章。确定了高级别证据以指导几个关键领域的实践,包括患者体温、液体管理、血管升压药使用、抗凝和镇痛使用。
目前的做法仍然极为多样。可以从现有文献中确定改善患者预后的关键策略。关键的循证指南包括围手术期应维持正常体温以改善预后(证据水平2b),每小时液体补充量应维持在3.5至6.0毫升/千克之间(证据水平2b)。血管升压药不会损害预后,可能会改善皮瓣血流(证据水平1b),大多数证据支持使用去甲肾上腺素而非其他血管升压药(证据水平1b)。应避免使用右旋糖酐(证据水平1b),在游离皮瓣乳房重建后,局部麻醉药输注泵系统有益(证据水平1b)。进一步的前瞻性研究将提高现有证据的质量。